ライフサイエンスコーパス: corneal transplantation

1 s in preventing graft rejection in high-risk corneal transplantation.

2 -cell (Treg) function, and graft survival in corneal transplantation.

3 nity, we used the murine model of orthotopic corneal transplantation.

4 upregulated after transplantation underwent corneal transplantation.

5 ed from residual corneal rims after surgical corneal transplantation.

6 d intracorneal ring segments, in addition to corneal transplantation.

7 ent developments in refractive surgery after corneal transplantation.

8 orneal buttons were processed at the time of corneal transplantation.

9 helium is the most important single layer in corneal transplantation.

10 he corneal endothelium and its importance to corneal transplantation.

11 stered to mice thrice a day after allogeneic corneal transplantation.

12 m question of transmission of cancer through corneal transplantation.

13 cellular apoptosis occur 1 week after human corneal transplantation.

14 cking gamma delta T cells with GL3 Ab before corneal transplantation.

15 ay a critical role in tolerance induction in corneal transplantation.

16 h earlier than would otherwise be seen after corneal transplantation.

17 ral loss of vision, eventually necessitating corneal transplantation.

18 lindness that results can be treated only by corneal transplantation.

19 dministered orally 10 days before orthotopic corneal transplantation.

20 conjugated with CTB and administered before corneal transplantation.

21 transplants, we examined the role of FasL in corneal transplantation.

22 have potential application in the setting of corneal transplantation.

23 for data-driven patient counseling prior to corneal transplantation.

24 isting Fuchs dystrophy, necessitating future corneal transplantation.

25 a later requirement for contact lens wear or corneal transplantation.

26 l for CEnC function and graft survival after corneal transplantation.

27 l for CEnC function and graft survival after corneal transplantation.

28 tion and time from first glaucoma surgery to corneal transplantation.

29 g glaucoma surgery, cataract extraction, and corneal transplantation.

30 ne glaucoma surgery, cataract extraction, or corneal transplantation.

31 nd the requirement for a repeated, high-risk corneal transplantation.

32 erve as an alternative to conventional donor corneal transplantation.

33 % of the world's population had no access to corneal transplantation.

34 hom 9335 had a unilateral and 2487 bilateral corneal transplantation.

35 ection), high-risk cases, and indication for corneal transplantation.

36 raft survival in a murine model of high-risk corneal transplantation.

37 uses of short and long-term graft failure in corneal transplantation.

38 cellent visual acuity remains a challenge in corneal transplantation.

39 the primary cause of fungal infection after corneal transplantation.

40 10 patients (71%), 6 (43%) of whom required corneal transplantation.

41 argets for enhancing CEnC survival following corneal transplantation.

42 r, necessitating and expediting the need for corneal transplantation.

43 l for suppressing immunological rejection in corneal transplantation.

44 urrence of endotheliitis within 1 year after corneal transplantation.

45 edian of 10 months (range 3-11 months) after corneal transplantation.

46 es that can affect the visual outcomes after corneal transplantation.

47 and quiescence for at least 6 months before corneal transplantation.

48 rom preoperative aqueous PCR analysis before corneal transplantation.

49 ndothelium and is the leading indication for corneal transplantation.

50 spond to medical treatment and ended up with corneal transplantation.

51 dystrophy (FECD) is a leading indication for corneal transplantation.

52 me of patients who have undergone successful corneal transplantation.

53 79.2%), cataract extraction (7 eyes, 29.2%), corneal transplantation (7 eyes, 29.2%), and glaucoma su

54 us had a higher rate of requiring subsequent corneal transplantation (7 of 10) compared to those with

55 Because HLA typing is not routine in corneal transplantation, a clear correlation between acc

56 This year, articles on corneal transplantation after conjunctival flaps, suture

57 Four eyes underwent corneal transplantation after successful ICN, with no ma

58 e long-term likelihood and time-to-event for corneal transplantation after trabeculectomy versus tube

59 After orthotopic corneal transplantation, all grafts were evaluated for s

60 ularization of high-risk patients undergoing corneal transplantation, allogeneic donor corneas are tr

61 orneal dystrophy (FCD) is a leading cause of corneal transplantation and affects 5% of persons in the

62 Corneal transplantation and corneal procurements per cap

63 genital glaucoma was the main indication for corneal transplantation and despite the difficulties, pr

64 l with national and international reports on corneal transplantation and eye banking.

65 echnology with regard to its applications in corneal transplantation and eye banking.

66 n this article, we review changing trends in corneal transplantation and highlight developing medical

67 ect both ametropia and astigmatism following corneal transplantation and improve a patient's final vi

68 in the sera of high-risk patients undergoing corneal transplantation and of control subjects.

69 Tissue scarcity poses global challenges for corneal transplantation and public health.

70 dels were used to evaluate the likelihood of corneal transplantation and time from first glaucoma sur

71 l (E)-selectin mediate T cell recruitment in corneal transplantation and whether their blockade can r

72 olvement, concomitant diagnoses of diabetes, corneal transplantation, and herpetic keratitis were ass

73 raphic characteristics, history of diabetes, corneal transplantation, and herpetic keratitis.

74 treatments and outcomes in cataract surgery, corneal transplantation, and macular degeneration.

75 significantly improving graft survival in HR corneal transplantation, and showing promising potential

76 eoretical risk for monkeypox transmission by corneal transplantation, and the Eye Bank Association of

77 All patients in group 1 had successful corneal transplantation, and the grafts remained clear w

78 SH has cytoprotective effects on CEnCs after corneal transplantation, and the loss of MC1R signaling

79 SH has cytoprotective effects on CEnCs after corneal transplantation, and the loss of MC1R signaling

80 n the United States and accounts for >14,000 corneal transplantations annually.

81 onor corneas and safety issues in performing corneal transplantation are the main limitations.

82 Many patients who have undergone corneal transplantation are unable to achieve satisfacto

83 In the United States alone, over 40,000 corneal transplantations are performed each year.

84 Corneal transplantations are surgeries performed for irr

85 ld-type (WT) versus TSP-1 null allografts in corneal transplantation, as the cornea is a rich source

86 atients 65 years old and older who underwent corneal transplantation at Wills Eye Institute from Apri

87 ing that persistent epithelial defects after corneal transplantation can be a serious complication, h

88 While corneal transplantation can successfully restore sight i

89 e beneficiaries had higher risk of requiring corneal transplantation compared to White beneficiaries

90 n the form of corneal gluing and therapeutic corneal transplantation compared with the failed-graft g

91 urrence of endotheliitis within 1 year after corneal transplantation, compared with CMV-negative eyes

92 ds to severe vision impairment As opposed to corneal transplantation; corneal collagen crosslinking (

93 ion is the leading cause of graft failure in corneal transplantation (CT) despite the immune privileg

94 han 5 million individuals, with over 180,000 corneal transplantations (CTs) performed annually.

95 The human-to-cat xenograft model of corneal transplantation demonstrated endothelial cell lo

96 Corneal transplantation, either with full-thickness or p

97 incidence of CE and the subsequent need for corneal transplantation following cataract surgery.

98 ransplantation Patient Registry as receiving corneal transplantation for KC from 1980 through 1986.

99 secutive eyes of 1438 patients who underwent corneal transplantation for optical indication at the Ce

100 secutive eyes of 1438 patients who underwent corneal transplantation for optical indication at the Ce

101 The available treatment options include corneal transplantation for significant corneal defects

102 Outcomes of corneal transplantation for tectonic indications and ris

103 l rehabilitation, and to reduce the need for corneal transplantation for these patients.

104 able that may be used to reduce the need for corneal transplantation for these patients.

105 tions captured were blindness or low vision, corneal transplantation, glaucoma, and cataract surgery.

106 disease progression, and the probability of corneal transplantation, graft failure, or both were cal

107 Corneal transplantation has evolved rapidly over the pas

108 arm of an immune response) after normal-risk corneal transplantation improves long-term graft surviva

109 eedingly rare corneal disorder that requires corneal transplantation in advanced stages.

110 the etiology, visual outcome and survival of corneal transplantation in children and to identify the

111 utine endothelial keratoplasty procedure for corneal transplantation in human patients.

112 healing that could provide an alternative to corneal transplantation in patients with blindness from

113 ft tissue critically limits accessibility to corneal transplantation in some parts of the world.

114 neal thinning, is the leading indication for corneal transplantation in the developed world.

115 ntation to reduce donor shortage and cost in corneal transplantation in the future.

116 was to demonstrate the publication trends of corneal transplantation in the last decade.

117 represents one of the most common causes of corneal transplantation in the United States.

118 endothelium and is the most common cause of corneal transplantation in the United States.

119 Using a model of orthotopic corneal transplantation in which allografts were placed

120 In a clinically relevant model of high-risk corneal transplantation in which blood and lymphatic ves

121 barriers to healthcare access and enhancing corneal transplantation infrastructure are crucial for e

122 cornea has a higher relative suitability for corneal transplantation into humans compared to other st

123 Before corneal transplantation, intrastromal sutures were place

124 The precise role of antibodies in corneal transplantation is ambiguous, with evidence to s

125 Although corneal transplantation is effective in restoring vision

126 This technique of corneal transplantation is more effective in eyes with s

127 transplantation or who live in regions where corneal transplantation is not possible.

128 Corneal transplantation is one of the most prevalent and

129 The likelihood of corneal transplantation is over 4 times higher after tub

130 Corneal transplantation is the most common form of solid

131 Corneal transplantation is the most common form of tissu

132 Corneal transplantation is the most common solid organ t

133 Corneal transplantation is the oldest, most common, and

134 Currently, corneal transplantation is the only established therapy

135 Corneal transplantation is the only measure currently av

136 Corneal transplantation is the only treatment available

137 have used rat and mouse models of orthotopic corneal transplantation (keratoplasty) in an attempt to

138 Human corneal transplantation (keratoplasty) is typically cons

139 reased rejection of corneal allografts after corneal transplantation (keratoplasty).

140 Both techniques of corneal transplantation led to a significant improvement

141 Using 2 well-established models of corneal transplantation (low-risk and high-risk models),

142 The success of corneal transplantation mainly relies on the integrity o

143 Genetic modulation of donor tissue before corneal transplantation may have the potential to modula

144 the graft-host interface using the high-risk corneal transplantation model.

145 rine corneal suture-induced NV and high-risk corneal transplantation models were used to evaluate the

146 both corneal suture-induced NV and high-risk corneal transplantation models, and this effect was lost

147 nly underwent tube shunts had a mean time to corneal transplantation of 2.49 years (standard deviatio

148 fts observed in contralateral low-risk or HR corneal transplantation of BALB/c recipient mice, respec

149 tients whose eye disease is not suitable for corneal transplantation or who live in regions where cor

150 aract surgery (OR, 0.31; 95% CI, 0.30-0.32), corneal transplantation (OR, 0.39; 95% CI, 0.31-0.49), a

151 ions by using the key words 'keratoplasty', 'corneal transplantation' or 'keratoprosthesis' in the 't

152 Corneal transplantation outcomes are generally less favo

153 episode of graft rejection within 5 years of corneal transplantation (P = .49).

154 In a model of corneal transplantation, P- and E-selectin mediate T cel

155 4 subjects were identified from the Michigan Corneal Transplantation Patient Registry as receiving co

156 (FECD), one of the commonest indications for corneal transplantation performed in developed countries

157 elium and is responsible for majority of the corneal transplantation performed in the United States.

158 Female sex decreased likelihood of requiring corneal transplantation post-operatively (OR 0.56 [0.36-

159 The success of corneal transplantations predates the use of corticoster

160 gender, previous cataract surgery, previous corneal transplantation, previous retina surgery, level

161 Subsequent corneal transplantation procedures performed in the same

162 m keratometry (K(max)), thinnest pachymetry, corneal transplantation rates, corneal scarring incidenc

163 High-risk corneal transplantation refers to grafting performed on

164 From a long-standing national corneal transplantation register, 13 920 penetrating ker

165 nti-CD80/86 antibodies in a murine high-risk corneal transplantation rejection model.

166 risk of steroid-induced IOP elevation after corneal transplantation relative to placebo.

167 Although visual rehabilitation after corneal transplantation remains a formidable challenge,

168 Corneal transplantation represents an interesting model

169 Corneal transplantation, reserved for advanced cases, si

170 Corneal transplantation restores visual function when vi

171 In recent case series, corneal transplantation revealed unexpected damage to th

172 Although corneal transplantation service is affected by various f

173 elopments have been achieved in the field of corneal transplantation since the introduction of steroi

174 performed in conjunction with newer forms of corneal transplantation such as deep anterior lamellar k

175 e have been no cases of HCV transmission via corneal transplantation, suggesting that current cadaver

176 A look at the recent advances in corneal transplantation surgery using the femtosecond la

177 To describe trends in corneal transplantation surgery, including indications f

178 Although corneal transplantation techniques have improved conside

179 In human corneal transplantation the value of matching, particula

180 ical and basic insights related to high-risk corneal transplantation, the factors associated with gra

181 tion of Tregs in a mouse model of orthotopic corneal transplantation, the most common form of tissue

182 Following corneal transplantation, there is an initial, rapid decl

183 n patients undergoing vascularized high-risk corneal transplantation, there was no statistically sign

184 We used a murine model of orthotopic corneal transplantation to determine whether host defici

185 neal opacification that were not amenable to corneal transplantation using human cadaveric keratoplas

186 xpression of chemokines in a murine model of corneal transplantation was determined by real time RT-P

187 Adjusted likelihood of corneal transplantation was highest with both trabeculec

188 Corneal transplantation was most frequently observed amo

189 High-risk corneal transplantation was performed between normal C57

190 Fully mismatched orthotopic corneal transplantation was performed in BALB/c hosts th

191 Orthotopic corneal transplantation was performed in fully mismatche

192 Orthotopic corneal transplantation was performed in hemevascularize

193 Orthotopic mouse corneal transplantation was performed in two fully misma

194 Allogeneic corneal transplantation was performed on inflamed host b

195 Allogeneic corneal transplantation was performed using C57BL/6 dono

196 Corneal transplantation was performed using C57BL/6 dono

197 Orthotopic corneal transplantation was performed, with recipients r

198 Corneal transplantation was required or planned in 55 (3

199 at high risk for rejection who had undergone corneal transplantation was used for immunoscreening of

200 A murine model of allogeneic corneal transplantation was used in the study, and graft

201 for corneal graft rejection after high-risk corneal transplantation, we conducted this prospective,

202 well-established murine model of allogeneic corneal transplantation, we investigated the immunomodul

203 In this study, using a mouse model of corneal transplantation, we investigated whether enrichm

204 Using a well-characterized murine model of corneal transplantation, we report that mast cells promo

205 Using a well-characterized murine model of corneal transplantation, we show that silencing CD80 in

206 In a murine model of allogeneic corneal transplantation, we used PCR and immunohistochem

207 Corneoscleral rims retained after corneal transplantation were incubated with and without

208 Murine models of high-risk and low-risk corneal transplantation were used to determine the role

209 to BALB/c) and syngeneic (BALB/c to BALB/c) corneal transplantations were performed and occurrence a

210 In high-risk corneal transplantation, where the graft bed is inflamed

211 re a valuable option in obtaining grafts for corneal transplantation, which is why we are working tow

212 s complications, and, ultimately, successful corneal transplantation with acceptable long-term graft

213 helial disorder and the most common cause of corneal transplantation worldwide.